William Nassib William MD

PubMed

• 5 citations
  Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection.
  Xiuning Le, Frederico O Gleber-Netto, M Laura Rubin, Yun Qing, Robyn Du
  Clinical Cancer Research. 2022-04-20
• 54 citations
  ISA101 and nivolumab for HPV-16cancer: updated clinical efficacy and immune correlates of response.
  Luana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, Renee L Chin, Lei Feng
  Journal for Immunotherapy of Cancer. 2022-02-01
• 30 citations
  Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
  Ming Chen, Runzhe Chen, Ying Jin, Jun Li, Xin Hu
  Nature Communications. 2021-11-17

Journal Articles

• PI3‐Kinase Pathway Biomarkers in Oral Cancer and Tumor Immune Cells  
  Bonnie S Glisson, Jeffrey Myers, N Jr William, Renata Ferrarotto, Head & Neck
• Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients with Incurable Human Papillomavirus 16–Related Cancer  
  Erminia Massarelli, William William, Ming Guo, Merrill Kies, Bonnie Glisson, Hai Tran, Faye Johnson, Renata Ferrarotto, Lei Feng, JAMA
• Landscape of EGFR -Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Post-Progression in EGFR-Mutant NSCLC  
  Stephen G Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach, Jack A Roth, Jianjun Zhang, William N William, Bonnie S Glisson, Clinical Cancer Research

Lectures

• Genomic and transcriptomic landscape of oral pre-cancers (OPCs) and risk of oral cancer (OC). 
  2019 ASCO Annual Meeting - 6/1/2019
• Probing the Depths of Immunotherapy: More Than Survival 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018